BCAB
Bioatla Inc
Price:  
0.32 
USD
Volume:  
98,739.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bioatla Fair Value

-1,944.95 %
Upside

What is the fair value of Bioatla?

As of 2025-04-21, the Fair Value of Bioatla Inc (BCAB) is -5.97 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.32 USD, the upside of Bioatla Inc is -1,944.95%.

Is Bioatla a good investment?

With the market price of 0.32 USD and our fair value calculation, Bioatla Inc (BCAB) is not a good investment. Investing in Bioatla stocks now will result in a potential loss of 1,944.95%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.32 USD
Stock Price
-5.97 USD
Fair Price
FAIR VALUE CALCULATION

Bioatla Fair Value

Peter Lynch's formula is:

Bioatla Fair Value
= Earnings Growth Rate x TTM EPS
Bioatla Fair Value
= 5.00 x -1.19
Bioatla Fair Value
= -5.97

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -35.85 -95.40 -106.48 -123.46 -69.78 -86.19
YoY growth -20.34% -166.11% -11.61% -15.95% 43.48% -34.11%

Bioatla Fair Value - Key Data

Market Cap (mil) 18.91
P/E
Forward P/E
EPS -1.19
Avg earnings growth rate -34.11%
TTM earnings -69.78